Cargando…

Exercise as therapy for Parkinson's?

Detalles Bibliográficos
Autores principales:	Crowley, Erin K., Nolan, Yvonne M., Sullivan, Aideen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075441/ https://www.ncbi.nlm.nih.gov/pubmed/30036186 http://dx.doi.org/10.18632/aging.101503

Ejemplares similares

Neurotrophic factor therapy for Parkinson's disease: past, present and future
por: Sullivan, Aideen M., et al.
Publicado: (2016)

Neuronal Signaling: an introduction
por: Sullivan, Aideen M.
Publicado: (2016)

Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2014)

Expression of endogenous Mkp1 in 6-OHDA rat models of Parkinson’s disease
por: Collins, Louise M, et al.
Publicado: (2014)

The Epigenome as a therapeutic target for Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2016)

Inhibition of Neuroinflammation May Mediate the Disease-Modifying Effects of Exercise: Implications for Parkinson’s Disease
por: Darweesh, Sirwan K.L., et al.
Publicado: (2022)

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2017)

The class II histone deacetylases as therapeutic targets for Parkinson’s disease
por: Mazzocchi, Martina, et al.
Publicado: (2020)

Protocol for evaluation of neurotrophic strategies in Parkinson’s disease-related dopaminergic and sympathetic neurons in vitro
por: Hegarty, Shane V., et al.
Publicado: (2016)

Dyskinesia in Parkinson's Disease Therapy
por: Carta, Anna Rosa, et al.
Publicado: (2012)

Targeting bone morphogenetic protein signalling in midbrain dopaminergic neurons as a therapeutic approach in Parkinson's disease
por: O'Keeffe, Gerard W., et al.
Publicado: (2017)

The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease
por: Goulding, Susan R., et al.
Publicado: (2020)

Transplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's disease
por: Costello, Daniel J, et al.
Publicado: (2012)

Editorial: The Role of Stem Cells, Epigenetics and MicroRNAs in Parkinson's Disease
por: Hegarty, Shane V., et al.
Publicado: (2020)

Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1/5-dependent mechanism: implications for Parkinson’s disease
por: Hegarty, Shane V., et al.
Publicado: (2018)

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease
por: Goulding, Susan R., et al.
Publicado: (2021)

Could exercise hormone irisin be a therapeutic agent against Parkinson’s and other neurodegenerative diseases?
por: Avgerinos, Konstantinos I., et al.
Publicado: (2023)

Diet quality, sleep and quality of life in Parkinson’s disease: a cross-sectional study
por: Dunk, Danielle, et al.
Publicado: (2022)

Familial Parkinson's Disease/Parkinsonism
por: Tomiyama, Hiroyuki, et al.
Publicado: (2015)

Mitochondria and Parkinson's Disease
por: Simon, David K., et al.
Publicado: (2011)

Rehabilitation and Parkinson's Disease
por: Earhart, Gammon M., et al.
Publicado: (2012)

People with Parkinson’s as Partners for the Journal of Parkinson’s Disease
por: McFarthing, Kevin, et al.
Publicado: (2023)

Optimisation of cardiac resynchronisation therapy during exercise
por: Ghani, A., et al.
Publicado: (2013)

Critical Analyses of Mechanism-Based Therapies Against Parkinson’s Disease: Concepts and Perspectives
Publicado: (2016)

Alpha-synuclein alters the faecal viromes of rats in a gut-initiated model of Parkinson’s disease
por: Stockdale, Stephen R., et al.
Publicado: (2021)

Rehabilitation and Parkinson's Disease 2013
por: Earhart, Gammon M., et al.
Publicado: (2013)

Studies on Nucleic Acids During Carcinogenesis
por: O'Sullivan, M. Aideen, et al.
Publicado: (1964)

Nonmotor Symptoms of Parkinson's Disease
por: Rektorova, Irena, et al.
Publicado: (2011)

Nonmotor Symptoms of Parkinson's Disease
por: Wu, Shey-Lin, et al.
Publicado: (2017)

Enhanced Exercise Therapy in Parkinson’s disease: A comparative effectiveness trial
por: Ridgel, Angela L., et al.
Publicado: (2015)

Targeting the value of targeted therapy
por: Paggio, Joseph C. Del, et al.
Publicado: (2017)

Mitochondria: Key Organelle in Parkinson's Disease
por: Gómez-Sánchez, Rubén, et al.
Publicado: (2016)

Ascertainment Bias in Anaphylaxis Safety Data of COVID-19 Vaccines
por: Hourihane, Jonathan O’B., et al.
Publicado: (2021)

Epidemiology of Parkinsonism and Parkinson's disease in Sub-Saharan Africa: Nigerian profile
por: Akinyemi, Rufus O
Publicado: (2012)

Neuropsychiatry of Parkinson's Disease
por: Teixeira, Antonio L., et al.
Publicado: (2012)

Inflammation and Parkinson's Disease
por: Barcia, Carlos, et al.
Publicado: (2011)

Cannabidiol in Parkinson’s disease
por: Rieder, Carlos R.
Publicado: (2020)

Gait in Parkinson's Disease
por: Martinez-Ramirez, Daniel, et al.
Publicado: (2019)

Neurobiology of Parkinson’s Disease
por: Morelli, Micaela, et al.
Publicado: (2023)

Neuronal Signaling: A reflection on the Biochemical Society’s newest journal and an exciting outlook on its next steps
por: Sullivan, Aideen M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f71fk6edv7dugigrdo0knedt0h